No Data
Eternal Bio-B (06978.HK): Liang Ruibing appointed as authorized representative.
Great Wisdom Report December 2nd | Yongtai Life Sciences - B (06978.HK) announced that Chen Ran has resigned as joint company secretary and authorized representative for other business responsibilities, effective from December 2, 2024. The company's other current joint company secretary, Liang Ruibing, a person qualified and experienced under Listing Rule 3.28 as company secretary, will continue to serve and act as the company's sole company secretary. Liang Ruibing has been appointed as an authorized representative, effective from December 2, 2024.
IMMUNOTECH-B: 2024 INTERIM REPORT
Eternal Biology-B (06978.HK) announced its interim performance, with a 22.6% year-on-year increase in R&D expenses.
Glory Times August 23rd | Yongtai Biology-B (06978.HK) announced its interim performance, the group's other income increased by approximately RMB 5.533 million for the six months ended June 30, 2023, to approximately RMB 6.526 million for the six months ended June 30, 2024, mainly due to an increase in government grants during the reporting period. The group's R&D expenses increased by approximately RMB 74.3 million for the six months ended June 30, 2023, to approximately RMB 91.1 million for the six months ended June 30, 2024, mainly due to the report.
Express News | Immunotech Biopharm - Hy Loss Attributable RMB92.5 Mln
Express News | Immunotech Biopharm H1 Pretax Profit RMB -92.6 Million
IMMUNOTECH-B: ANNOUNCEMENT OF THE INTERIM RESULTSFOR THE SIX MONTHS ENDED 30 JUNE 2024
